These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32765848)

  • 1. Targeting vulnerable atherosclerotic plaque via PET-tracers aiming at cell-surface overexpression of somatostatin receptors.
    Z Papadakis G; Kochiadakis G; Lazopoulos G; Marias K; Klapsinos N; Hannah-Shmouni F; G Igoumenaki G; Konstantinos Nikolouzakis T; Kteniadakis S; A Spandidos D; H Karantanas A
    Biomed Rep; 2020 Sep; 13(3):9. PubMed ID: 32765848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.
    Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A
    Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.
    Mojtahedi A; Alavi A; Thamake S; Amerinia R; Ranganathan D; Tworowska I; Delpassand ES
    Am J Nucl Med Mol Imaging; 2015; 5(1):65-71. PubMed ID: 25625028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice.
    Li X; Bauer W; Kreissl MC; Weirather J; Bauer E; Israel I; Richter D; Riehl G; Buck A; Samnick S
    Atherosclerosis; 2013 Sep; 230(1):33-9. PubMed ID: 23958249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting Vulnerable Atherosclerotic Plaques by
    Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
    Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 64Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy.
    Pedersen SF; Sandholt BV; Keller SH; Hansen AE; Clemmensen AE; Sillesen H; Højgaard L; Ripa RS; Kjær A
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1696-703. PubMed ID: 25977567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients.
    Malmberg C; Ripa RS; Johnbeck CB; Knigge U; Langer SW; Mortensen J; Oturai P; Loft A; Hag AM; Kjær A
    J Nucl Med; 2015 Dec; 56(12):1895-900. PubMed ID: 26429961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond
    Bucerius J; Dijkgraaf I; Mottaghy FM; Schurgers LJ
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):251-265. PubMed ID: 30302506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
    Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pet tracers for vulnerable plaque imaging.
    Giannakou S; Angelidis G; Tsougos I; Valotassiou V; Kappas K; Georgoulias P
    Ann Nucl Med; 2020 May; 34(5):305-313. PubMed ID: 32193790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR).
    Anzola LK; Rivera JN; Ramirez JC; Signore A; Mut F
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using
    Weiberg D; Thackeray JT; Daum G; Sohns JM; Kropf S; Wester HJ; Ross TL; Bengel FM; Derlin T
    J Nucl Med; 2018 Feb; 59(2):266-272. PubMed ID: 28775206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
    Bala G; Blykers A; Xavier C; Descamps B; Broisat A; Ghezzi C; Fagret D; Van Camp G; Caveliers V; Vanhove C; Lahoutte T; Droogmans S; Cosyns B; Devoogdt N; Hernot S
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):1001-8. PubMed ID: 26800768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
    Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
    J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
    J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B; Asopa R; Basu S
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of [
    Kiugel M; Hellberg S; Käkelä M; Liljenbäck H; Saanijoki T; Li XG; Tuomela J; Knuuti J; Saraste A; Roivainen A
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30513758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.